GRCE · Categories · Form 4
GRCE - SEC Form 4 insider transactions
Grace Therapeutics Inc. (GRCE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for GRCE
- SEC Form 4 filed by Director Kavuru Vimal4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by Director Neugeboren Edward4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by Director Davis A Brian4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by Director Kottayil George4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by Director Kottayil George4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by Director Davis A Brian4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by Director Kavuru Vimal4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by Director Neugeboren Edward4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Macdonald R. Loch4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by VP Program Management Kumar Amresh4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by VP Clinical Operations D'Andrea Carrie4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by Principal Financial Officer Delaversano Robert J4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Kohli Prashant4 - Grace Therapeutics, Inc. (0001444192) (Issuer)